Association between severe disease course and nephritis with Q222R polymorphism in DNAse I gene among lupus patients: An Argentine multicenter study
Authors
Gabriela Camicia; Sebastián Andres Muñoz; Alberto Allievi; Alberto Omar Orden; Silvia Perés Wingeyer; Rosana Trobo; Alicia Eimon; Juan Carlos Barreira; Emilce Schneeberger; Judith Sarano; Julio Hofman; Gabriela de Larrañaga; Federico Aranda;
Abstract
Objetives: Systemic lupus erythematosus is a multifactorial autoimmune disease and the glomerulonephritis is one of the most severe complications, which leads to severe persistent proteinuria, chronic renal failure, and end-stage renal disease. This multicenter study investigated the genetic associations of a non-synonymous single-nucleotide polymorphism in DNase I with the risk of lupus and its influence on development of nephropathy in an Argentinean population.
Methods: Using the Polymerase chain reaction restriction fragment length polymorphism method, the Q222R (+2373A→G; Gln244Arg) DNase I polymorphism was studied in 156 systemic lupus erythematosus patients and 170 healthy controls.
Results: Although no significant association between Q222R polymorphism and the risk of systemic lupus erythematosus was found, the presence of the A allele was associated with an increased risk for the development of nephropathy (p=0.019, Odd Ratio=2.196, 95 % confidence interval [1.135-4.247]) and a worse disease course [moderate disease course: p=0.006, Odd Ratio=3.250, 95% confidence interval (1.401-7.539); severe disease course: p=0.040, Odd Ratio=2.339, 95% confidence interval (1.040-5.260)].
Conclusions: A better understanding of the genetic basis of systemic lupus erythematosus will help in the development of new and more effectives strategies for the treatment of the disease in the future.
Gabriela Camicia
Hospital de Infecciosas Dr. F. Muñiz
Sebastián Andres Muñoz
Hospital General de Agudos Dr. J. A. Fernández
Alberto Allievi
Hospital General de Agudos Dr. J. A. Fernández
Alberto Omar Orden
Clínica San Camilo
Silvia Perés Wingeyer
Hospital de Infecciosas Dr. F. Muñiz
Rosana Trobo
Hospital Dr. B Sommer
Alicia Eimon
Hospital Dr. J. Penna
Juan Carlos Barreira
Hospital Británico
Emilce Schneeberger
Instituto de Rehabilitación Psicofísica
Judith Sarano
Instituto de Investigaciones Médicas Dr. A. Lanari;
Julio Hofman
H.I.G.A. E. Perón. Buenos Aires, Argentina.
Gabriela de Larrañaga
Hospital de Infecciosas Dr. F. Muñiz
Federico Aranda
Hospital de Infecciosas Dr. F. Muñiz
Hospital de Infecciosas Dr. F. Muñiz
Sebastián Andres Muñoz
Hospital General de Agudos Dr. J. A. Fernández
Alberto Allievi
Hospital General de Agudos Dr. J. A. Fernández
Alberto Omar Orden
Clínica San Camilo
Silvia Perés Wingeyer
Hospital de Infecciosas Dr. F. Muñiz
Rosana Trobo
Hospital Dr. B Sommer
Alicia Eimon
Hospital Dr. J. Penna
Juan Carlos Barreira
Hospital Británico
Emilce Schneeberger
Instituto de Rehabilitación Psicofísica
Judith Sarano
Instituto de Investigaciones Médicas Dr. A. Lanari;
Julio Hofman
H.I.G.A. E. Perón. Buenos Aires, Argentina.
Gabriela de Larrañaga
Hospital de Infecciosas Dr. F. Muñiz
Federico Aranda
Hospital de Infecciosas Dr. F. Muñiz